CAPEOX/XELOX: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
7
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| Colorectal cancer | 2 |
| Colorectal Cancer (CRC) | 1 |
| Colorectal Carcinoma | 1 |
| MSS | 1 |
| Oligometastases | 1 |
| iTNT | 1 |
| pMMR | 1 |
Recruiting trials involving CAPEOX/XELOX
- Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
- SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases
Common questions
How many recruiting trials involve CAPEOX/XELOX?
2 recruiting trials across 7 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.